Oral cancers and precancerous mouth lesions are considered especially difficult to diagnose early and accurately.
FDA’s Janet Woodcock to retire in early 2024
Janet Woodcock, an FDA legend who for almost 40 years served as acting FDA commissioner, deputy commissioner and CDER director, among other roles, will retire